Literature DB >> 33572945

Foot-and-Mouth Disease Virus Evades Innate Immune Response by 3C-Targeting of MDA5.

Hyejin Kim1,2, Ah-Young Kim1, Jieun Choi1, Sun Young Park1,2, Sang Hyun Park1, Jae-Seok Kim1, Sim-In Lee1, Jong-Hyeon Park1, Choi-Kyu Park2, Young-Joon Ko1.   

Abstract

Foot-and-mouth disease (FMD) is a highly contagious disease caused by FMD virus (FMDV) in cloven-hoofed animals. Retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5) are representative receptors in the cytoplasm for the detection of viral RNA and trigger antiviral responses, leading to the production of type I interferon. Although MDA5 is a crucial receptor for sensing picornavirus RNA, the interplay between MDA5 and FMDV is relatively unknown compared to the interplay between RIG-I and FMDV. Here, we observed that the FMDV infection inhibits MDA5 protein expression. Of the non-structural proteins, the Lb and 3C proteinases (Lbpro and 3Cpro) were identified to be primarily responsible for this inhibition. However, the inhibition by 3Cpro was independent of proteasome, lysosome and caspase-dependent pathway and was by 3C protease activity. A direct interaction between 3Cpro and MDA5 protein was observed. In conclusion, this is the first report that 3Cpro inhibits MDA5 protein expression as a mechanism to evade the innate immune response during FMDV infection. These results elucidate the pathogenesis of FMDV and provide fundamental insights for the development of a novel vaccine or therapeutic agent.

Entities:  

Keywords:  3C; MDA5; foot-and-mouth disease virus; innate immune response; non-structural protein

Year:  2021        PMID: 33572945      PMCID: PMC7912020          DOI: 10.3390/cells10020271

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  46 in total

1.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses.

Authors:  Hiroki Kato; Osamu Takeuchi; Shintaro Sato; Mitsutoshi Yoneyama; Masahiro Yamamoto; Kosuke Matsui; Satoshi Uematsu; Andreas Jung; Taro Kawai; Ken J Ishii; Osamu Yamaguchi; Kinya Otsu; Tohru Tsujimura; Chang-Sung Koh; Caetano Reis e Sousa; Yoshiharu Matsuura; Takashi Fujita; Shizuo Akira
Journal:  Nature       Date:  2006-04-09       Impact factor: 49.962

2.  Foot-and-mouth disease virus non-structural protein 2B negatively regulates the RLR-mediated IFN-β induction.

Authors:  Ming Li; Ting Xin; Xintao Gao; Jing Wu; Xixi Wang; Lichun Fang; Xiukun Sui; Hongfei Zhu; Shangjin Cui; Xiaoyu Guo
Journal:  Biochem Biophys Res Commun       Date:  2018-08-31       Impact factor: 3.575

3.  Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced type I interferon transcription by decreasing interferon regulatory factor 3/7 in protein levels.

Authors:  Dang Wang; Liurong Fang; Rui Luo; Rui Ye; Ying Fang; Lilan Xie; Huanchun Chen; Shaobo Xiao
Journal:  Biochem Biophys Res Commun       Date:  2010-07-16       Impact factor: 3.575

4.  3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation.

Authors:  Yijun Du; Jingshan Bi; Jiyu Liu; Xing Liu; Xiangju Wu; Ping Jiang; Dongwan Yoo; Yongguang Zhang; Jiaqiang Wu; Renzhong Wan; Xiaomin Zhao; Lihui Guo; Wenbo Sun; Xiaoyan Cong; Lei Chen; Jinbao Wang
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

5.  Foot-and-Mouth Disease Virus 3B Protein Interacts with Pattern Recognition Receptor RIG-I to Block RIG-I-Mediated Immune Signaling and Inhibit Host Antiviral Response.

Authors:  Xiangle Zhang; Zixiang Zhu; Congcong Wang; Fan Yang; Weijun Cao; Pengfei Li; Xiaoli Du; Furong Zhao; Xiangtao Liu; Haixue Zheng
Journal:  J Immunol       Date:  2020-09-11       Impact factor: 5.422

6.  Foot-and-Mouth Disease Virus Viroporin 2B Antagonizes RIG-I-Mediated Antiviral Effects by Inhibition of Its Protein Expression.

Authors:  Zixiang Zhu; Guoqing Wang; Fan Yang; Weijun Cao; Ruoqing Mao; Xiaoli Du; Xiangle Zhang; Chuntian Li; Dan Li; Keshan Zhang; Hongbing Shu; Xiangtao Liu; Haixue Zheng
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

Review 7.  Molecular Mechanisms of Foot-and-Mouth Disease Virus Targeting the Host Antiviral Response.

Authors:  Miguel Rodríguez Pulido; Margarita Sáiz
Journal:  Front Cell Infect Microbiol       Date:  2017-06-13       Impact factor: 5.293

8.  Foot-and-mouth disease virus VP1 target the MAVS to inhibit type-I interferon signaling and VP1 E83K mutation results in virus attenuation.

Authors:  Pathum Ekanayaka; Seo-Yong Lee; Thilina U B Herath; Jae-Hoon Kim; Tae-Hwan Kim; Hyuncheol Lee; Kiramage Chathuranga; W A Gayan Chathuranga; Jong-Hyeon Park; Jong-Soo Lee
Journal:  PLoS Pathog       Date:  2020-11-24       Impact factor: 6.823

9.  MDA-5 recognition of a murine norovirus.

Authors:  Stephen A McCartney; Larissa B Thackray; Leonid Gitlin; Susan Gilfillan; Herbert W Virgin; Herbert W Virgin Iv; Marco Colonna
Journal:  PLoS Pathog       Date:  2008-07-18       Impact factor: 6.823

View more
  4 in total

Review 1.  Running With Scissors: Evolutionary Conflicts Between Viral Proteases and the Host Immune System.

Authors:  Brian V Tsu; Elizabeth J Fay; Katelyn T Nguyen; Miles R Corley; Bindhu Hosuru; Viviana A Dominguez; Matthew D Daugherty
Journal:  Front Immunol       Date:  2021-11-01       Impact factor: 7.561

2.  Direct Interaction of Coronavirus Nonstructural Protein 3 with Melanoma Differentiation-Associated Gene 5 Modulates Type I Interferon Response during Coronavirus Infection.

Authors:  Xinxin Sun; Li Quan; Ruiai Chen; Dingxiang Liu
Journal:  Int J Mol Sci       Date:  2022-10-02       Impact factor: 6.208

3.  DDX21, a Host Restriction Factor of FMDV IRES-Dependent Translation and Replication.

Authors:  Sahibzada Waheed Abdullah; Jin'en Wu; Yun Zhang; Manyuan Bai; Junyong Guan; Xiangtao Liu; Shiqi Sun; Huichen Guo
Journal:  Viruses       Date:  2021-09-03       Impact factor: 5.048

4.  Inhibition of MAVS Aggregation-Mediated Type-I Interferon Signaling by Foot-and-Mouth Disease Virus VP3.

Authors:  Pathum Ekanayaka; Byeong-Hoon Lee; Asela Weerawardhana; Kiramage Chathuranga; Jong-Hyeon Park; Jong-Soo Lee
Journal:  Viruses       Date:  2021-09-06       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.